<DOC>
	<DOCNO>NCT00079794</DOCNO>
	<brief_summary>The purpose study determine whether supplemental treatment Iscar improve immune function quality life among Stage IV non-small cell lung carcinoma patient receive conventional chemotherapy . Iscar herbal medicine make total plant extract mistletoe . preparation already use Europe use US likely increase cancer patient continue seek alternative therapy .</brief_summary>
	<brief_title>Iscar Supplemental Care Stage IV Lung Cancer</brief_title>
	<detailed_description>See Brief Summary</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Stage IV NSCLC patient receive standard chemotherapy Exclusion criterion : Known allergy Viscum Album L. Concomitant use mistletoe product Concomitant use mushroom glucan proteoglycan extract Concomitant use thymus extract product Inability selfreport quality life utilizing assessment tool Ongoing steroid ACTH therapy Comorbid immunocompromised state Pregnancy Participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>lung cancer</keyword>
	<keyword>herbal medicine</keyword>
	<keyword>non-small cell cancer</keyword>
	<keyword>Iscar</keyword>
	<keyword>mistletoe</keyword>
</DOC>